Recordati Industria Chimica e Farmaceutica S.p.A. (VIE:REC)

Market Cap	9.80B -13.1%
Revenue (ttm)	2.55B +12.6%
Net Income	404.39M -4.4%
EPS	1.93 -4.4%
Shares Out	n/a
PE Ratio	24.24
Forward PE	14.58
Dividend	1.30 (2.78%)
Ex-Dividend Date	Nov 24, 2025

Volume	n/a
Average Volume	24
Open	47.76
Previous Close	47.38
Day's Range	47.76 - 48.34
52-Week Range	44.06 - 60.25
Beta	n/a
RSI	46.32
Earnings Date	Feb 17, 2026

About VIE:REC

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally. It operates through Specialty and Primary Care; and Rare Diseases segments. The company develops REC 0545 for acute decompensation in maple syrup urine diseases; Isturia for endogenous Cushing’s syndrome; Cystadrops for corneal cystine crystal deposits; Carbaglu for hyperammonemia due ...

• Industry: Pharmaceutical Preparations
• Founded: 1926
• Employees: 4,583
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: REC

Financial Performance

In 2024, VIE:REC's revenue was 2.34 billion, an increase of 12.45% compared to the previous year's 2.08 billion. Earnings were 416.51 million, an increase of 7.01%.